Michael S. Brown - Nov 8, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Michael S. Brown
Stock symbol
REGN
Transactions as of
Nov 8, 2022
Transactions value $
-$1,726,794
Form type
4
Date filed
11/10/2022, 03:00 PM
Previous filing
Mar 31, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $909K +2.43K +224.68% $374.12 3.51K Nov 8, 2022 Direct F1
transaction REGN Common Stock Sale -$1.32M -1.76K -50.21% $748.48 1.75K Nov 8, 2022 Direct F1, F2
transaction REGN Common Stock Options Exercise $755K +1.56K +89.42% $482.68 3.31K Nov 8, 2022 Direct F1
transaction REGN Common Stock Sale -$94.7K -126 -3.8% $751.23 3.19K Nov 8, 2022 Direct F1, F3
transaction REGN Common Stock Sale -$153K -203 -6.37% $752.14 2.98K Nov 8, 2022 Direct F1, F4
transaction REGN Common Stock Sale -$226K -300 -10.05% $753.66 2.68K Nov 8, 2022 Direct F1, F5
transaction REGN Common Stock Sale -$151K -200 -7.45% $754.70 2.48K Nov 8, 2022 Direct F1, F6
transaction REGN Common Stock Sale -$152K -200 -8.05% $760.70 2.28K Nov 8, 2022 Direct F1, F7
transaction REGN Common Stock Sale -$76.2K -100 -4.38% $761.53 2.18K Nov 8, 2022 Direct F1
transaction REGN Common Stock Sale -$153K -200 -9.16% $763.19 1.98K Nov 8, 2022 Direct F1, F8
transaction REGN Common Stock Sale -$153K -200 -10.08% $764.23 1.78K Nov 8, 2022 Direct F1, F9
transaction REGN Common Stock Sale -$76.5K -100 -5.61% $765.19 1.68K Nov 8, 2022 Direct F1
transaction REGN Common Stock Sale -$154K -201 -11.94% $766.74 1.48K Nov 8, 2022 Direct F1, F10
transaction REGN Common Stock Sale -$154K -201 -13.55% $767.25 1.28K Nov 8, 2022 Direct F1, F11
transaction REGN Common Stock Sale -$154K -200 -15.6% $768.11 1.08K Nov 8, 2022 Direct F1, F12
transaction REGN Common Stock Sale -$374K -500 -6.98% $748.49 6.66K Nov 8, 2022 by Trust F1
holding REGN Common Stock 5K Nov 8, 2022 by SLAT F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.43K -100% $0.00* 0 Nov 8, 2022 Common Stock 2.43K $374.12 Direct F1, F14
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.56K -43.29% $0.00 2.05K Nov 8, 2022 Common Stock 1.56K $482.68 Direct F1, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 1,764 shares of Company stock on November 8, 2022 at prices ranging from $748.24 to $748.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 126 shares of Company stock on November 8, 2022 at prices ranging from $751.10 to $751.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 203 shares of Company stock on November 8, 2022 at prices ranging from $752.02 to $752.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 300 shares of Company stock on November 8, 2022 at prices ranging from $753.15 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $754.68 to $754.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $760.50 to $760.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $763.18 to $763.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $764.10 to $764.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F10 Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $766.59 to $766.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F11 Represents volume-weighted average price of sales of 201 shares of Company stock on November 8, 2022 at prices ranging from $767.09 to $767.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F12 Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2022 at prices ranging from $768.08 to $768.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2022 at each separate price.
F13 These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F14 On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.